Previous studies showed that Ki67 is a prognostic marker in many tumors, such as colorectal cancer, breast cancer, lymphoma, prostate cancer, and laryngeal cancer.18, 19, 20, 21, 22. This evidence concerns the gene MKI67 and breast carcinoma.